cetylpyridinium chloride anhydrous has been researched along with Liposarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aloj, L; Aurilio, M; Borrelli, A; Grieco, P; Lorizio, R; Mancini, A; Mancini, R; Mazzarella, L; Morelli, F; Novellino, E; Occhiello, A; Pagnozzi, D; Pica, A; Pucci, P; Rommelaere, J; Schiattarella, A; Sica, A; Sica, F | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Liposarcoma
| Article | Year |
|---|---|
Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Base Sequence; Biochemical Phenomena; Biochemistry; Biophysical Phenomena; Biophysics; Cell Line, Tumor; Chromatography, Affinity; Circular Dichroism; Estradiol; Health; Humans; Hydrogen Peroxide; Liposarcoma; Mice; Mice, Nude; Molecular Sequence Data; Peptide Mapping; Recombinant Proteins; Sequence Analysis; Spectrometry, Mass, Electrospray Ionization; Superoxide Dismutase; Xenograft Model Antitumor Assays | 2008 |